National Vision Holdings Inc... Show more
National Vision Holdings (EYE) stands as one of the largest value-oriented optical retailers in the U.S., operating over 1,270 stores across brands like America’s Best (primary revenue driver), Eyeglass World, and Vista Optical in host locations such as Fred Meyer and military bases. In a highly fragmented $69.5 billion optical retail market dominated by independents, the company leverages national scale for efficient procurement, centralized labs, and managed care participation (42% of revenue, targeting 50%).
Competitive edges include bundled pricing (e.g., exams with multiple pairs), remote telehealth in 800+ stores, AI retinal imaging, and refreshed branding emphasizing "Every Eye Deserves Better." America’s Best outpaces category exam growth, gaining share amid optometry consolidation. Eyeglass World benefits from on-site labs for quick turnaround. Host partnerships provide stable traffic, bolstered by recent military expansions. Challenges include rivals like EssilorLuxottica, Specsavers, Walmart, and DTC players (e.g., Warby Parker), but EYE’s value focus and omni-channel (7% e-commerce) support medium-term market share gains in a resilient, non-discretionary sector.
National Vision’s trajectory hinges on execution of transformation initiatives. Fiscal Q2 earnings (expected August 2026) will update progress on 2026 guidance, with focus on adjusted comp sales and margins. Store segmentation and premium lens strategies aim to boost average ticket, building on Q1’s 4.5% adjusted comp growth from higher tickets and managed care.
Partnership expansions, like the April 2026 Army & Air Force deal adding 20 Vista Optical military stores, secure recurring revenue from vision benefits. New store openings (30-35, mostly America’s Best) and Eyeglass World conversions target high-return locations post-2026 moderation. Analyst upgrades post-Q1 (e.g., UBS to $42, Citi to $40) reflect optimism, with consensus Moderate Buy and $32-$35 average targets signaling improving sentiment amid premium mix shifts and cost discipline. These could drive re-rating if execution sustains.
The U.S. optical retail sector (~$70 billion, growing via aging demographics, digital eye strain, and 170 million vision-corrected adults) favors recurring, medically necessary demand resilient to cycles. National Vision benefits from managed care tailwinds (42% mix, higher-value cohorts) and telehealth amid optometrist shortages.
Macro sensitivities include consumer spending (discretionary eyewear vulnerable to inflation/recession, especially self-pay traffic) and interest rates (variable debt ~$242 million, partially swapped). Easing rates could aid capex ($73-78 million guidance); persistent inflation pressures wages/labor (13,000+ associates). Geopolitical risks affect frame/lens imports (vendor concentration); regulatory shifts in telehealth/vision benefits pose hurdles. Overall, value positioning buffers downturns versus premium peers.
Tickeron’s Trend Prediction Engine is an AI-powered forecasting tool that helps traders identify whether a stock, ETF, or other asset may move bullish, bearish, or sideways over the next week or month. It leverages advanced machine learning to analyze historical patterns, technical indicators, and market data, enabling users to spot developing trends, evaluate possible breakouts or reversals, and explore predictions across a wide range of tradable instruments. The tool includes searchable prediction categories, historical performance context for accuracy assessment, and alert functionality to notify users of potential shifts. Designed for both novice and experienced investors, it provides data-driven insights to inform trading strategies. Explore the Trend Prediction Engine today to enhance your market analysis.
Fiscal 2026 guidance underscores confidence: $2.033-$2.091 billion revenue (3-6% adjusted comps), $107-133 million adjusted operating income, and $0.85-1.09 adjusted EPS, with 30-35 stores and capex of $73-78 million. Long-term, National Vision targets margin expansion (50-150 bps annually through 2030) via premiumization, managed care scale-up, and AI/telehealth efficiencies. Store growth reaccelerates to 60/year from 2028 (~240 by 2030), prioritizing America’s Best.
Themes include market expansion in underserved areas, cost evolution through supply chain optimization, sustainable margins from higher-mix sales, technology transitions (smart eyewear, CRM), and competitive threats from DTC/e-commerce. Regulatory tailwinds in vision benefits and capital allocation (debt reduction, buybacks) will shape sentiment. Consensus forecasts align with ~25% EPS growth, supporting analyst upside.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations
an operator of retail locations offering eye exams, eyeglasses and contact lenses
Industry SpecialtyStores
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| RAAX | 41.09 | 0.91 | +2.26% |
| VanEck Real Assets ETF | |||
| PAYH | 24.92 | 0.09 | +0.37% |
| TrueShares S&P Autocallable High Inc ETF | |||
| QTOC | 37.59 | 0.13 | +0.36% |
| Innovator Growth Accelertd Pls ETF™ Oct | |||
| REMC | 21.99 | N/A | N/A |
| Columbia Research Enhanced Mid Cap ETF | |||
| PTIN | 36.55 | -0.04 | -0.10% |
| Pacer Trendpilot International ETF | |||
A.I.dvisor indicates that over the last year, EYE has been loosely correlated with HNST. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if EYE jumps, then HNST could also see price increases.
| Ticker / NAME | Correlation To EYE | 1D Price Change % | ||
|---|---|---|---|---|
| EYE | 100% | +1.97% | ||
| HNST - EYE | 47% Loosely correlated | +1.97% | ||
| LOW - EYE | 43% Loosely correlated | -0.12% | ||
| CPRT - EYE | 43% Loosely correlated | -1.00% | ||
| CWH - EYE | 42% Loosely correlated | +3.10% | ||
| FND - EYE | 42% Loosely correlated | -0.80% | ||
More | ||||
EYE saw its Momentum Indicator move above the 0 level on June 10, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 82 similar instances where the indicator turned positive. In of the 82 cases, the stock moved higher in the following days. The odds of a move higher are at .
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where EYE's RSI Indicator exited the oversold zone, of 33 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for EYE just turned positive on June 01, 2026. Looking at past instances where EYE's MACD turned positive, the stock continued to rise in of 44 cases over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where EYE advanced for three days, in of 287 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where EYE declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
EYE broke above its upper Bollinger Band on June 11, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for EYE entered a downward trend on May 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.559) is normal, around the industry mean (4.902). P/E Ratio (32.658) is within average values for comparable stocks, (29.588). EYE's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.350). EYE has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.029). P/S Ratio (0.747) is also within normal values, averaging (1.296).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. EYE’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. EYE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock worse than average.